Clinical Trial

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)

Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-12-11; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2023-08-23
Trial Details
NCT Number NCT05657743
Lead Sponsor Alpha Tau Medical LTD.
Conditions Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma
Enrollment 15 participants
Start Date 2023-08-16
Primary Completion 2026-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-16